Torin2 enhances the radiosensitivity of MCF‑7 breast cancer cells by downregulating the mTOR signaling pathway and ATM phosphorylation
Cited by 14
Related Papers
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
|Cancer Cell|2024|177
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC
|Clinical Cancer Research|2020|123
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status
|Journal for ImmunoTherapy of Cancer|2020|58